nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—Ileus paralytic—Vincristine—colon cancer	0.0615	0.0615	CcSEcCtD
Dihydrocodeine—Ileus paralytic—Capecitabine—colon cancer	0.0401	0.0401	CcSEcCtD
Dihydrocodeine—Urinary retention—Vincristine—colon cancer	0.0184	0.0184	CcSEcCtD
Dihydrocodeine—Hepatic enzyme increased—Methotrexate—colon cancer	0.0136	0.0136	CcSEcCtD
Dihydrocodeine—Hallucination—Vincristine—colon cancer	0.0133	0.0133	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Vincristine—colon cancer	0.0132	0.0132	CcSEcCtD
Dihydrocodeine—Urethral disorder—Vincristine—colon cancer	0.0131	0.0131	CcSEcCtD
Dihydrocodeine—Angiopathy—Vincristine—colon cancer	0.0121	0.0121	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Vincristine—colon cancer	0.012	0.012	CcSEcCtD
Dihydrocodeine—Urinary retention—Capecitabine—colon cancer	0.012	0.012	CcSEcCtD
Dihydrocodeine—Mood swings—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Dihydrocodeine—Angiopathy—Irinotecan—colon cancer	0.0118	0.0118	CcSEcCtD
Dihydrocodeine—Immune system disorder—Irinotecan—colon cancer	0.0117	0.0117	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Irinotecan—colon cancer	0.0117	0.0117	CcSEcCtD
Dihydrocodeine—Mental disorder—Vincristine—colon cancer	0.0117	0.0117	CcSEcCtD
Dihydrocodeine—Vertigo—Vincristine—colon cancer	0.0104	0.0104	CcSEcCtD
Dihydrocodeine—Vertigo—Irinotecan—colon cancer	0.0102	0.0102	CcSEcCtD
Dihydrocodeine—Convulsion—Vincristine—colon cancer	0.0101	0.0101	CcSEcCtD
Dihydrocodeine—Convulsion—Fluorouracil—colon cancer	0.0094	0.0094	CcSEcCtD
Dihydrocodeine—Confusional state—Irinotecan—colon cancer	0.00932	0.00932	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Vincristine—colon cancer	0.0093	0.0093	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Vincristine—colon cancer	0.00917	0.00917	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Capecitabine—colon cancer	0.00917	0.00917	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Irinotecan—colon cancer	0.00906	0.00906	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Irinotecan—colon cancer	0.00893	0.00893	CcSEcCtD
Dihydrocodeine—Confusional state—Fluorouracil—colon cancer	0.00892	0.00892	CcSEcCtD
Dihydrocodeine—Mood swings—Methotrexate—colon cancer	0.00887	0.00887	CcSEcCtD
Dihydrocodeine—Hypotension—Vincristine—colon cancer	0.00887	0.00887	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Fluorouracil—colon cancer	0.00868	0.00868	CcSEcCtD
Dihydrocodeine—Hypotension—Irinotecan—colon cancer	0.00863	0.00863	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Capecitabine—colon cancer	0.0086	0.0086	CcSEcCtD
Dihydrocodeine—Urethral disorder—Capecitabine—colon cancer	0.00853	0.00853	CcSEcCtD
Dihydrocodeine—Paraesthesia—Vincristine—colon cancer	0.00852	0.00852	CcSEcCtD
Dihydrocodeine—Paraesthesia—Irinotecan—colon cancer	0.0083	0.0083	CcSEcCtD
Dihydrocodeine—Hypotension—Fluorouracil—colon cancer	0.00827	0.00827	CcSEcCtD
Dihydrocodeine—Dyspnoea—Irinotecan—colon cancer	0.00824	0.00824	CcSEcCtD
Dihydrocodeine—Somnolence—Irinotecan—colon cancer	0.00821	0.00821	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Vincristine—colon cancer	0.00819	0.00819	CcSEcCtD
Dihydrocodeine—Constipation—Vincristine—colon cancer	0.00811	0.00811	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00798	0.00798	CcSEcCtD
Dihydrocodeine—Paraesthesia—Fluorouracil—colon cancer	0.00795	0.00795	CcSEcCtD
Dihydrocodeine—Constipation—Irinotecan—colon cancer	0.0079	0.0079	CcSEcCtD
Dihydrocodeine—Angiopathy—Capecitabine—colon cancer	0.0079	0.0079	CcSEcCtD
Dihydrocodeine—Dyspnoea—Fluorouracil—colon cancer	0.00789	0.00789	CcSEcCtD
Dihydrocodeine—Somnolence—Fluorouracil—colon cancer	0.00787	0.00787	CcSEcCtD
Dihydrocodeine—Immune system disorder—Capecitabine—colon cancer	0.00786	0.00786	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Capecitabine—colon cancer	0.00785	0.00785	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Vincristine—colon cancer	0.00776	0.00776	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00764	0.00764	CcSEcCtD
Dihydrocodeine—Mental disorder—Capecitabine—colon cancer	0.00763	0.00763	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Irinotecan—colon cancer	0.00761	0.00761	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Irinotecan—colon cancer	0.00756	0.00756	CcSEcCtD
Dihydrocodeine—Abdominal pain—Vincristine—colon cancer	0.0075	0.0075	CcSEcCtD
Dihydrocodeine—Abdominal pain—Irinotecan—colon cancer	0.0073	0.0073	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Fluorouracil—colon cancer	0.00729	0.00729	CcSEcCtD
Dihydrocodeine—Urticaria—Fluorouracil—colon cancer	0.00703	0.00703	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—colon cancer	0.00683	0.00683	CcSEcCtD
Dihydrocodeine—Vertigo—Capecitabine—colon cancer	0.00681	0.00681	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vincristine—colon cancer	0.00649	0.00649	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00641	0.00641	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—colon cancer	0.0064	0.0064	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—colon cancer	0.00635	0.00635	CcSEcCtD
Dihydrocodeine—Diarrhoea—Irinotecan—colon cancer	0.00632	0.00632	CcSEcCtD
Dihydrocodeine—Dry mouth—Capecitabine—colon cancer	0.00631	0.00631	CcSEcCtD
Dihydrocodeine—Dizziness—Vincristine—colon cancer	0.00627	0.00627	CcSEcCtD
Dihydrocodeine—Pruritus—Fluorouracil—colon cancer	0.00626	0.00626	CcSEcCtD
Dihydrocodeine—Confusional state—Capecitabine—colon cancer	0.00624	0.00624	CcSEcCtD
Dihydrocodeine—Dizziness—Irinotecan—colon cancer	0.00611	0.00611	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Capecitabine—colon cancer	0.00606	0.00606	CcSEcCtD
Dihydrocodeine—Diarrhoea—Fluorouracil—colon cancer	0.00606	0.00606	CcSEcCtD
Dihydrocodeine—Vomiting—Vincristine—colon cancer	0.00603	0.00603	CcSEcCtD
Dihydrocodeine—Skin disorder—Capecitabine—colon cancer	0.00601	0.00601	CcSEcCtD
Dihydrocodeine—Rash—Vincristine—colon cancer	0.00598	0.00598	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Capecitabine—colon cancer	0.00598	0.00598	CcSEcCtD
Dihydrocodeine—Dermatitis—Vincristine—colon cancer	0.00598	0.00598	CcSEcCtD
Dihydrocodeine—Headache—Vincristine—colon cancer	0.00594	0.00594	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—colon cancer	0.00588	0.00588	CcSEcCtD
Dihydrocodeine—Vomiting—Irinotecan—colon cancer	0.00588	0.00588	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—colon cancer	0.00585	0.00585	CcSEcCtD
Dihydrocodeine—Dizziness—Fluorouracil—colon cancer	0.00585	0.00585	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—colon cancer	0.00584	0.00584	CcSEcCtD
Dihydrocodeine—Rash—Irinotecan—colon cancer	0.00583	0.00583	CcSEcCtD
Dihydrocodeine—Dermatitis—Irinotecan—colon cancer	0.00582	0.00582	CcSEcCtD
Dihydrocodeine—Headache—Irinotecan—colon cancer	0.00579	0.00579	CcSEcCtD
Dihydrocodeine—Hypotension—Capecitabine—colon cancer	0.00578	0.00578	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—colon cancer	0.00568	0.00568	CcSEcCtD
Dihydrocodeine—Nausea—Vincristine—colon cancer	0.00564	0.00564	CcSEcCtD
Dihydrocodeine—Vomiting—Fluorouracil—colon cancer	0.00563	0.00563	CcSEcCtD
Dihydrocodeine—Rash—Fluorouracil—colon cancer	0.00558	0.00558	CcSEcCtD
Dihydrocodeine—Dermatitis—Fluorouracil—colon cancer	0.00557	0.00557	CcSEcCtD
Dihydrocodeine—Paraesthesia—Capecitabine—colon cancer	0.00555	0.00555	CcSEcCtD
Dihydrocodeine—Headache—Fluorouracil—colon cancer	0.00554	0.00554	CcSEcCtD
Dihydrocodeine—Dyspnoea—Capecitabine—colon cancer	0.00551	0.00551	CcSEcCtD
Dihydrocodeine—Nausea—Irinotecan—colon cancer	0.00549	0.00549	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00534	0.00534	CcSEcCtD
Dihydrocodeine—Constipation—Capecitabine—colon cancer	0.00529	0.00529	CcSEcCtD
Dihydrocodeine—Nausea—Fluorouracil—colon cancer	0.00526	0.00526	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Capecitabine—colon cancer	0.0051	0.0051	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—colon cancer	0.00507	0.00507	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Capecitabine—colon cancer	0.00506	0.00506	CcSEcCtD
Dihydrocodeine—Urticaria—Capecitabine—colon cancer	0.00491	0.00491	CcSEcCtD
Dihydrocodeine—Abdominal pain—Capecitabine—colon cancer	0.00489	0.00489	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—colon cancer	0.00489	0.00489	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00477	0.00477	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—colon cancer	0.00464	0.00464	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—colon cancer	0.00451	0.00451	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—colon cancer	0.00447	0.00447	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—colon cancer	0.00445	0.00445	CcSEcCtD
Dihydrocodeine—Pruritus—Capecitabine—colon cancer	0.00438	0.00438	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—colon cancer	0.0043	0.0043	CcSEcCtD
Dihydrocodeine—Diarrhoea—Capecitabine—colon cancer	0.00423	0.00423	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—colon cancer	0.00413	0.00413	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—colon cancer	0.0041	0.0041	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—colon cancer	0.00409	0.00409	CcSEcCtD
Dihydrocodeine—Dizziness—Capecitabine—colon cancer	0.00409	0.00409	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00397	0.00397	CcSEcCtD
Dihydrocodeine—Vomiting—Capecitabine—colon cancer	0.00393	0.00393	CcSEcCtD
Dihydrocodeine—Rash—Capecitabine—colon cancer	0.0039	0.0039	CcSEcCtD
Dihydrocodeine—Dermatitis—Capecitabine—colon cancer	0.0039	0.0039	CcSEcCtD
Dihydrocodeine—Headache—Capecitabine—colon cancer	0.00387	0.00387	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—colon cancer	0.00379	0.00379	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—colon cancer	0.00376	0.00376	CcSEcCtD
Dihydrocodeine—Nausea—Capecitabine—colon cancer	0.00367	0.00367	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—colon cancer	0.00366	0.00366	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—colon cancer	0.00364	0.00364	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—colon cancer	0.00326	0.00326	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—colon cancer	0.00315	0.00315	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—colon cancer	0.00304	0.00304	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—colon cancer	0.00293	0.00293	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—colon cancer	0.0029	0.0029	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—colon cancer	0.0029	0.0029	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—colon cancer	0.00288	0.00288	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—colon cancer	0.00273	0.00273	CcSEcCtD
